纳米递送系统在增强 CAR-T/CRISPR-Cas9 介导的癌症治疗中的新兴优势
Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics.
FRONTIER PAPERS
Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics.
Lung metastasis and recurrence is mitigated by CAR macrophages, in-situ-generated from mRNA delivered by small extracellular vesicles.
Advancements in Nanomedicine for Precision Management of Lymphoma: Mechanisms, Diagnostics, and Therapeutic Strategies.
Components, Formulations, Deliveries, and Combinations of Tumor Vaccines.
Recent advances in dendritic cell-derived exosomes in cancer and cancer stem cell therapy.
Applications of mRNA Delivery in Cancer Immunotherapy.
Non-viral and mRNA-based strategies for next-generation CAR-T cell therapy.
The Limitations of Current T Cell-Driven Anticancer Immunotherapies Can Be Overcome with an Original Extracellular-Vesicle-Based Vaccine Strategy.
共 9 条
MEMBER ACCOUNT
登录成功会直接打开下一页。